Feedback Form
Join, Follow & Connect
Join Modern Healthcare's LinkedIn group Follow Modern Healthcare on Twitter Join Modern Healthcare's Facebook group Join Modern Healthcare's Flickr group Get a Modern Healthcare news feed
 
 
Comment Buy Reprints Print Article Share on LinkedIn Share on Facebook Share on Twitter Email this page to a colleague
Healthcare Business News
 

Transcript: Mark Neaman, president and CEO of the NorthShore University HealthSystem in Evanston, Ill.


Posted: August 17, 2009 - 12:01 am ET
Tags:

David Burda: Hello everyone. This is Dave Burda, editor of Modern Healthcare and Modern Physician magazines. Visiting with us today is Mark Neaman, president and CEO of the NorthShore University HealthSystem based in Evanston, Ill. In 2007, the Federal Trade Commission ruled that NorthShore's acquisition of a third hospital way back in the year 2000 violated federal antitrust law. The ruling allowed NorthShore to keep the third hospital but operate under a rigid set of contracting rules. Mark, your system decided not to appeal the FTC's ruling. What factors led you to that decision?

Mark Neaman: A couple of different factors were important at the time. One was that we had spent about five years and a considerable sum of money in dealing with the overall agreement with the Federal Trade Commission. We thought at the time that the agreement was livable for us, and principally that we were able to keep the Highland Park (Ill.) Hospital as a part of our family. Given that the future costs and risks association with appeal were pretty big, we thought it best to accept the deal that we had, the arrangement that had been worked out with the Federal Trade Commission, and to positively move ahead.

David Burda: How has NorthShore functioned under the rules set out by the Federal Trade Commission?

Mark Neaman: We've been very fortunate. The hospitals have worked very well together. It has not been an onerous kind of a solution that we entered into with the Federal Trade Commission. We're very diligent in making sure that we undertake all of the steps that are required by the Federal Trade Commission. But we've been able to move ahead quite successfully.

Advertisement | View Media Kit

 

David Burda: Mark, how has the ruling affected NorthShore's expansion strategy?

Mark Neaman: The agreement does not adversely affect our expansion plans in the sense that we were able to also have a merger with an additional hospital in the area. What is has changed is the process of looking at expansion plans and working closely with the Federal Trade Commission in advance of any considerations of possible mergers or acquisitions.

David Burda: Mark, what advice would you have for other CEOs facing a Federal Trade Commission antitrust investigation?

Mark Neaman: My only suggestion would be to work directly with the Federal Trade Commission in advance, to work with your legal counsel, to ask questions. They're pretty good about taking your situations and reviewing them in advance and trying to get kind of a feel of whether or not this may or may not be an issue in advance of undertaking any mergers or acquisitions.

David Burda: Does NorthShore have any current expansion plans that you could tell our readers?

Mark Neaman: We're always looking in the marketplace. There has been an announcement that we have had a discussion with a physician group in town. But we have nothing final on that one way or another.

David Burda: Mark, thanks again for visiting with us today.

Search ModernHealthcare.com:



Daily Dose MH Alert MH AM HITS Modern Physician Most Requested Advance Notice

LinkedIn Amazon Kindle Twitter Facebook Flickr News Feeds